Medicine: Sanofi builds new insulin factory in Frankfurt for billions
The pharmaceutical company is building a new production facility for insulin in Frankfurt. This is important for diabetics and is also significant far beyond the location.
Sanofi has started building a new insulin production facility in Frankfurt, investing around two billion euros. The facility, set to be operational by 2032, will replace an existing one and ensure a stable insulin supply for diabetics in Germany and Europe. The new plant, covering 36,000 square meters, will utilize artificial intelligence and meet the highest standards.
Sanofi's CEO, Belen Garijo, emphasized the importance of the facility, stating that millions of people worldwide rely on insulin daily. The project has received 400 million euros in state aid from the EU, German government, and the state of Hessen.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
